Mechanisms Linking Glucose Homeostasis and Iron Metabolism Toward the Onset and Progression of Type 2 Diabetes

Diabetes Care

Volumn 38, Issue 11, 2015, Pages 2169-2176

  Ferńandez Real, José Manuel ^a,b   Mcclain, Donald ^c,d   Review, Melania Manco ^e  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d Veterans Administration   (United States)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CD71 ANTIGEN; COPPER; GLUCOSE; HEME; HEPCIDIN; INSULIN; IRON; LIPID;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CELL DIFFERENTIATION; CIRCADIAN RHYTHM; COPPER METABOLISM; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DUODENUM; DYSMETABOLIC HEPATIC IRON OVERLOAD SYNDROME; DYSMETABOLIC HYPERFERRITINEMIA; ERYTHROCYTE FRAGILITY; ERYTHROPHAGOCYTOSIS; EXERCISE; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; HEME SYNTHESIS; HORMONE ACTION; HUMAN; HYPERFERRITINEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; IRON ABSORPTION; IRON DEFICIENCY; IRON INTAKE; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; LIPID DIET; LIPOGENESIS; LIPOHYPERTROPHY; LIPOLYSIS; METABOLIC REGULATION; METABOLIC SYNDROME X; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; SENESCENCE; SMALL INTESTINE ABSORPTION; STARVATION; TISSUE METABOLISM; HOMEOSTASIS; METABOLISM;

DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN; IRON;

EID: 84962449221     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-3082     Document Type: Article

References (66)

1. Finch C. Regulators of iron balance in humans. Blood 1994;84:1697-1702.
2. Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004;27:2422-2428.
3. Cohen LA, Gutierrez L, Weiss A, et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 2010;116:1574-1584.
4. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell 2010;142: 24-38.
5. Sheftel AD, Mason AB, Ponka P. The long history of iron in the universe and in health and disease. Biochim Biophys Acta 2012;1820:161-187.
6. Ganz T. Systemic iron homeostasis. Physiol Rev 2013;93:1721-1741.
7. Root HF. Insulin resistance and bronze diabetes. N Engl J Med 1929;201:201-206.
8. Pietrangelo A. Hemochromatosis: An endocrine liver disease. Hepatology 2007;46:1291- 1301.
9. Mendler MH, Turlin B, Moirand R, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999;117:1155-1163.
10. Fernández-Real JM, Ricart-Engel W, Arroyo E, et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 1998;21:62-68.
11. Fernández-Real JM, Lopez-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 2002;51:2348-2354.
12. Bozzini C, Girelli D, Olivieri O, et al. Prevalence of body iron excess in the metabolic syndrome. Diabetes Care 2005;28:2061-2063.
13. Salonen JT, Tuomainen TP, Nyyssönen K, Lakka HM, Punnonen K. Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ 1998;317:727.
14. Swaminathan S, Fonseca VA, Alam MG, Shah SV. The role of iron in diabetes and its complications. Diabetes Care 2007;30:1926-1933.
15. Simcox JA, McClain DA. Iron and diabetes risk. Cell Metab 2013;17:329-341.
16. Fernández-Real JM, Manco M. Effects of iron overload on chronic metabolic diseases. Lancet Diabetes Endocrinol 2014;2:513-526.
17. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-2093.
18. Niederau C, Berger M, Stremmel W, et al. Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia 1984;26:441-444.
19. Davis RJ, Corvera S, Czech MP. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem 1986;261: 8708-8711.
20. Wang H, Li H, Jiang X, Shi W, Shen Z, Li M. Hepcidin is directly regulated by insulin and plays an important role in iron overload in streptozotocin-induced diabetic rats. Diabetes 2014;63:1506-1518.
21. Ferrannini E. Insulin resistance, iron, and the liver. Lancet 2000;355:2181-2182.
22. Valenti L, Canavesi E, Galmozzi E, et al. Betaglobin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol 2010;53:927-933.
23. Ruivard M, Lainé F, Ganz T, et al. Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin. J Hepatol 2009;50: 1219-1225.
24. Ruivard M. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: An update]. Rev Med Interne 2009;30: 35-42.
25. Meli R, MattaceRaso G, Irace C, et al. High fat diet induces liver steatosis and early dysregulation of iron metabolism in rats. PLoS One 2013;8:e66570.
26. Simcox JA, Mitchell TC, Gao Y, et al. Dietary iron controls circadian hepatic glucose metabolism through heme synthesis. Diabetes 2015;64: 1108-1119.
27. Vecchi C, Montosi G, Garuti C, et al. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice. Gastroenterology 2014;146: 1060-1069.
28. Martinelli N, Traglia M, Campostrini N, et al. Increased serum hepcidin levels in subjects with the metabolic syndrome: A population study. PLoS One 2012;7:e48250.
29. Barisani D, Pelucchi S, Mariani R, et al. Hepcidin and iron-related gene expression in subjects with dysmetabolic hepatic iron overload. J Hepatol 2008;49:123-133.
30. Dongiovanni P, Fracanzani AL, Fargion S, Valenti L. Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target. J Hepatol 2011;55:920-932.
31. Turlin B, Mendler MH, Moirand R, Guyader D, Guillygomarc'h A, Deugnier Y. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients. Am J Clin Pathol 2001;116:263-270.
32. De Domenico I, Ward DM, di Patti MC, et al. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J 2007;26:2823-2831.
33. Aigner E, Theurl I, Haufe H, et al. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease. Gastroenterology 2008;135:680-688.
34. Otogawa K, Kinoshita K, Fujii H, et al. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. Am J Pathol 2007;170:967-980.
35. Alústiza JM, Artetxe J, Castiella A, et al.; Gipuzkoa Hepatic Iron Concentration by MRI Study Group. MR quantification of hepatic iron concentration. Radiology 2004;230:479-484.
36. Schafer AI, Cheron RG, Dluhy R, et al. Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 1981;304:319- 324.
37. Fernández-Real JM, Izquierdo M, Moreno- Navarrete JM, et al. Circulating soluble transferrin receptor concentration decreases after exerciseinduced improvement of insulin sensitivity in obese individuals. Int J Obes 2009;33:768-774.
38. Xu J, Hwang JC, Lees HA, et al. Long-term perturbation of muscle iron homeostasis following hindlimb suspension in old rats is associated with high levels of oxidative stress and impaired recovery from atrophy. Exp Gerontol 2012;47:100-108.
39. Atamna H, Walter PB, Ames BN. The role of heme and iron-sulfur clusters in mitochondrial biogenesis, maintenance, and decay with age. Arch Biochem Biophys 2002;397:345-353.
40. De Ruisseau KC, Park YM, De Ruisseau LR, Cowley PM, Fazen CH, Doyle RP. Aging-related changes in the iron status of skeletal muscle. Exp Gerontol 2013;48:1294-1302.
41. Potashnik R, Kozlovsky N, Ben-Ezra S, Rudich A, Bashan N. Regulation of glucose transport and GLUT-1 expression by iron chelators in muscle cells in culture. Am J Physiol 1995;269: E1052-E1058.
42. Huang J, Simcox J, Mitchell TC, et al. Iron regulates glucose homeostasis in liver and muscle via AMP-activated protein kinase in mice. FASEB J 2013;27:2845-2854.
43. Moreno-Navarrete JM, Novelle MG, Catalán V, et al. Insulin resistance modulates iron-related proteins in adipose tissue. Diabetes Care 2014;37:1092-1100.
44. Festa M, Ricciardelli G, Mele G, Pietropaolo C, Ruffo A, Colonna A. Overexpression of H ferritin and up-regulation of iron regulatory protein genes during differentiation of 3T3-L1 preadipocytes. J Biol Chem 2000;275:36708-36712.
45. Dongiovanni P, Ruscica M, Rametta R, et al. Dietary iron overload induces visceral adipose tissue insulin resistance. Am J Pathol 2013;182: 2254-2263.
46. Cooksey RC, Jones D, Gabrielsen S, et al. Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am J Physiol Endocrinol Metab 2010;298:E1236- E1243.
47. Tajima S, Ikeda Y, Sawada K, et al. Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. Am J Physiol Endocrinol Metab 2012;302:E77-E86.
48. Rumberger JM, Peters T Jr, Burrington C, Green A. Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes. Diabetes 2004;53:2535-2541.
49. Moreno-Navarrete JM, Ortega F, Moreno M, Ricart W, Fernández-Real JM. Fine-tuned iron availability is essential to achieve optimal adipocyte differentiation and mitochondrial biogenesis. Diabetologia 2014;57:1957-1967.
50. Hubler MJ, Peterson KR, Hasty AH. Iron homeostasis: A new job for macrophages in adipose tissue? Trends Endocrinol Metab 2015; 26:101-109.
51. Sherman AR. Lipogenesis in iron-deficient adult rats. Lipids 1978;13:473-478.
52. Davis MR, Rendina E, Peterson SK, Lucas EA, Smith BJ, Clarke SL. Enhanced expression of lipogenic genes may contribute to hyperglycemia and alterations in plasma lipids in response to dietary iron deficiency. Genes Nutr 2012;7: 415-425.
53. Davies KJ, Donovan CM, Refino CJ, Brooks GA, Packer L, Dallman PR. Distinguishing effects of anemia and muscle iron deficiency on exercise bioenergetics in the rat. Am J Physiol 1984; 246:E535-E543.
54. Yamagishi H, Komabayashi T. Alteration of glucose metabolism and increased fructosamine in iron-deficiency anemic rats. Nutr Res 2003;23: 1547-1553.
55. Gabrielsen JS, Gao Y, Simcox JA, et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest 2012;122:3529-3540.
56. Moreno-Navarrete JM, Manco M, Ibanéz J, et al. Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Int J Obes 2010;34:240-249.
57. Fernández-Real JM, Casamitjana R, Ricart- Engel W. Leptin is involved in gender-related differences in insulin sensitivity. Clin Endocrinol (Oxf) 1998;49:505-511.
58. Fernández-Real JM, Moreno JM, Ricart W. Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload. Diabetes 2008;57:1918-1925.
59. Chung B, Matak P, McKie AT, Sharp P. Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr 2007;137:2366-2370.
60. Amato A, Santoro N, Calabrò P, et al. Effect of body mass index reduction on serum hepcidin levels and iron status in obese children. Int J Obes 2010;34:1772-1774.
61. Fernández-Real JM, Moreno JM, Chico B, López-Bermejo A, Ricart W. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance. Diabetes Care 2007;30:616-621.
62. Fernández-Real JM, Penarroja G, Castro A, García-Bragado F, Hernández-Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and b-cell function. Diabetes 2002;51:1000-1004.
63. McClain DA, Abraham D, Rogers J, et al. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia 2006;49:1661-1669.
64. Hudson DM, Curtis SB, Smith VC, et al. Human hephaestin expression is not limited to enterocytes of the gastrointestinal tract but is also found in the antrum, the enteric nervous system, and pancreatic beta-cells. Am J Physiol Gastrointest Liver Physiol 2010;298:G425-G432.
65. Ellervik C, Marott JL, Tybjærg-Hansen A, Schnohr P, Nordestgaard BG. Total and causespecific mortality by moderately and markedly increased ferritin concentrations: general population study and metaanalysis. Clin Chem 2014;60:1419-1428.
66. Ellervik C, Mandrup-Poulsen T, Tybjærg- Hansen A, Nordestgaard BG. Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes: Two general population studies. Diabetes Care 2014;37:444-452.